Crystal structure of botulinum neurotoxin subtype A3 cell binding domain in complex with GD1a co-receptor ganglioside

FEBS Open Bio. 2020 Mar;10(3):298-305. doi: 10.1002/2211-5463.12790. Epub 2020 Jan 28.

Abstract

Botulinum neurotoxins (BoNTs) are one of the most toxic proteins known to humans. Their molecular structure is comprised of three essential domains-a cell binding domain (HC ), translocation domain and catalytic domain (light chain) . The HC domain facilitates the highly specific binding of BoNTs to the neuronal membrane via a dual-receptor complex involving a protein receptor and a ganglioside. Variation in activity/toxicity across subtypes of serotype A has been attributed to changes in protein and ganglioside interactions, and their implications are important in the design of novel BoNT-based therapeutics. Here, we present the structure of BoNT/A3 cell binding domain (HC /A3) in complex with the ganglioside GD1a at 1.75 Å resolution. The structure revealed that six residues interact with the three outermost monosaccharides of GD1a through several key hydrogen bonding interactions. A detailed comparison of structures of HC /A3 with HC /A1 revealed subtle conformational differences at the ganglioside binding site upon carbohydrate binding.

Keywords: botulinum neurotoxin; cell binding domain; crystallography; ganglioside binding; protein structure.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Binding Sites / genetics
  • Botulinum Toxins / chemistry
  • Botulinum Toxins / metabolism
  • Botulinum Toxins / ultrastructure
  • Botulinum Toxins, Type A / metabolism
  • Botulinum Toxins, Type A / ultrastructure*
  • Carrier Proteins / metabolism
  • Cell Membrane / metabolism
  • Crystallography, X-Ray / methods
  • Gangliosides / metabolism*
  • Humans
  • Neurons / metabolism
  • Protein Binding
  • Protein Domains / genetics

Substances

  • Carrier Proteins
  • Gangliosides
  • ganglioside, GD1a
  • Botulinum Toxins
  • Botulinum Toxins, Type A